Cargando...
HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis
BACKGROUND: Patients with Multiple Sclerosis (PwMS) display altered lipoproteins levels and function, which seem to affect disease risk and progress. Whether disease-modifying therapies affect the lipoprotein profile in PwMS has scarcely been studied. OBJECTIVE: The study aims to assess whether fing...
Gardado en:
| Publicado en: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794658/ https://ncbi.nlm.nih.gov/pubmed/31662882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217319882720 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|